Following yesterday’s announcement of changes to its process for collecting daily COVID-19-reated data from hospitals, the Department of Health and Human Services today asked hospitals to prioritize the reporting of seven data fields starting tomorrow, July 15:

  • Previous day's new adult admissions for confirmed COVID-19
  • Previous day's new adult admissions for suspected COVID-19
  • Total adults hospitalized for COVID - suspected and confirmed
  • Total hospitalized for COVID - confirmed only
  • Total adults in ICU with COVID - suspected and confirmed
  • Total adults in ICU with COVID - confirmed
  • Remdesivir doses (field will be available by 7/15)

In an email sent to registered users of its TeleTracking portal, HHS states it is prioritizing these seven fields because they inform the agency’s distribution of remdesivir. Going forward, HHS will pull a week’s worth of data each Wednesday to inform its remdesivir distribution efforts. HHS states that remdesivir distributions will not be calculated correctly if data from each day are not reported.

While HHS has prioritized the collection of the seven data fields above for this week, the agency notes that it intends to use all of the data fields from hospital daily reporting for various resource allocations. HHS asks hospitals to begin reporting all of the data fields included in yesterday’s guidance on hospital reporting by no later than Wednesday, July 22.  

Related News Articles

Headline
The Food and Drug Administration today authorized the Moderna and Pfizer bivalent COVID-19 vaccines for emergency use in children as young as 6 months old.…
#HealthCareInnovation Thursday Blog
Early on in my professional journey as a physician, I had a calling to work with infectious diseases. Little did I know then how big a role this medical…
Headline
On Dec. 15, the Department of Health and Human Services will stop collecting hospitals’ COVID-19 data through the TeleTracking portal and begin collecting the…
Headline
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., today encouraged all eligible Americans to get vaccinated against the flu and…
Headline
The Food and Drug Administration does not currently authorize the monoclonal antibody bamlanivimab for emergency use to treat mild-to-moderate COVID-19 in the…
Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…